Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Treatment Approach for Breast Carcinoma

In Situ Disease Management

  • The National Comprehensive Cancer Network recommends observation alone as the preferred treatment for Lobular Carcinoma In Situ (LCIS) because the risk of developing invasive carcinoma is low (~21% over 15 years) 1, 2
  • LCIS is considered a risk marker for future breast cancer development in either breast, not a malignant lesion requiring surgical excision 3
  • Bilateral mastectomy should only be considered in special circumstances such as BRCA1/2 mutation or strong family history, and is NOT recommended for most women with LCIS 1, 2
  • Ductal Carcinoma In Situ (DCIS) requires active treatment with breast-conserving surgery plus adjuvant radiation therapy, which benefits all subgroups 4
  • Adjuvant tamoxifen should be considered for ER-positive DCIS 4
  • Complete excision with negative margins is essential for DCIS 3
  • The goal of treating DCIS is preventing development of invasive disease 5, 6

Invasive Disease Management

  • Treatment algorithms do NOT differ based on lobular versus ductal histology - both are treated according to stage, hormone receptor status, HER2 status, and risk stratification 1, 2
  • Key treatment decisions are based on endocrine responsiveness (ER/PR status) 4
  • Risk of relapse (tumor size, grade, nodal status) is also a key factor in treatment decisions 4
  • HER2 status is an important consideration in treatment planning 4
  • Stage and operability are also crucial in determining the treatment approach 1, 2
  • For locally advanced disease (T4), neoadjuvant chemotherapy is indicated regardless of histology, followed by surgery and radiation 7

Common Pitfalls to Avoid

  • The National Comprehensive Cancer Network recommends not treating LCIS like DCIS - LCIS requires observation, not aggressive surgical intervention in most cases 1, 2, 3

REFERENCES

1

breast cancer: noninvasive and special situations. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

2

breast cancer: noninvasive and special situations. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

5

breast cancer, version 4.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

6

breast cancer, version 4.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

7

Initial Management of T4 Invasive Lobular Breast Carcinoma [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025